{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:25:55Z","timestamp":1789053955492,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.hpb.2025.12.027","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:14:55Z","timestamp":1765844095000},"page":"524-533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Follow up and safety of use of hepatitis C virus discordant liver transplants"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6314-5412","authenticated-orcid":false,"given":"Catherine G.","family":"Pratt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6573-1611","authenticated-orcid":false,"given":"Nicolas","family":"Noriega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3306-4089","authenticated-orcid":false,"given":"Jenna N.","family":"Whitrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela M.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8298-742X","authenticated-orcid":false,"given":"Tiffany E.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina H.","family":"Lemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Luckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schoech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurram","family":"Bari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8851-7375","authenticated-orcid":false,"suffix":"III","given":"Ralph C.","family":"Quillin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-7310","authenticated-orcid":false,"given":"Shimul A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2025.12.027_bib1","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.ajt.2025.01.022","article-title":"OPTN\/SRTR 2023 annual data report: liver","volume":"25","author":"Kwong","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib2","series-title":"Organ Procurement & Transplantation Network","year":"2023"},{"key":"10.1016\/j.hpb.2025.12.027_bib3","year":"2024"},{"key":"10.1016\/j.hpb.2025.12.027_bib4","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.cgh.2023.04.005","article-title":"Liver transplantation 2023: status report, current and future challenges","volume":"21","author":"Terrault","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.12.027_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijsu.2020.05.059","article-title":"Current status of liver transplantation in North America","volume":"82S","author":"Kirchner","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.hpb.2025.12.027_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/cco-20-212","article-title":"Liver transplantation: expanding the donor and recipient pool","volume":"10","author":"Ahmed","year":"2021","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.hpb.2025.12.027_bib7","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.34067\/KID.0002472021","article-title":"Global perspective on kidney transplantation: united States","volume":"2","author":"Wang","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.hpb.2025.12.027_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000000918","article-title":"Kidney paired donation protocol for participating donors 2014","volume":"99","author":"Richardson","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.hpb.2025.12.027_bib9","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.transproceed.2015.04.006","article-title":"Marginal donors in renal transplantation","volume":"47","author":"Bozkurt","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hpb.2025.12.027_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","article-title":"Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation","volume":"148","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2025.12.027_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2025.12.027_bib12","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.27681","article-title":"Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation","volume":"61","author":"Forns","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2025.12.027_bib13","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","article-title":"An interferon-free antiviral regimen for HCV after liver transplantation","volume":"371","author":"Kwo","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hpb.2025.12.027_bib14","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.29704","article-title":"Hepatitis C transmission from seropositive, nonviremic donors to non\u2013hepatitis C liver transplant recipients","volume":"67","author":"Bari","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2025.12.027_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/lt.25741","article-title":"Use of hepatitis C nucleic acid test\u2013positive liver allografts in hepatitis C virus seronegative recipients","volume":"26","author":"Anwar","year":"2020","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib16","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/hep.30540","article-title":"Increasing utilization and excellent initial outcomes following liver transplant of hepatitis C virus (HCV)-viremic donors into HCV-negative recipients: outcomes following liver transplant of HCV-viremic donors","volume":"69","author":"Cotter","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2025.12.027_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13194","article-title":"Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients","volume":"21","author":"Ting","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.hpb.2025.12.027_bib18","article-title":"Liberalizing transplantation of HCV positive donor organs into HCV negative recipients","volume":"3","author":"Guttikonda","year":"2020","journal-title":"Digest Med Res"},{"key":"10.1016\/j.hpb.2025.12.027_bib19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhep.2020.11.005","article-title":"Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients","volume":"74","author":"Aqel","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.hpb.2025.12.027_bib20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/lt.25925","article-title":"Liver transplantation using hepatitis C virus-viremic donors into hepatitis C virus-aviremic recipients as standard of care","volume":"27","author":"Bohorquez","year":"2021","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib21","doi-asserted-by":"crossref","first-page":"100318","DOI":"10.1016\/j.aohep.2021.100318","article-title":"Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: a large single center analysis","volume":"24","author":"Sobotka","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.hpb.2025.12.027_bib22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/lt.25424","article-title":"Improved graft survival after liver transplantation for recipients with hepatitis C virus in the direct-acting antiviral era","volume":"25","author":"Cotter","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ajt.13976","article-title":"Changes in utilization and discard of hepatitis C-Infected donor livers in the recent era","volume":"17","author":"Bowring","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib24","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/TP.0000000000004116","article-title":"Varying utilization rates but superior outcomes in liver transplantation from hepatitis C-positive donors in the United States: an analysis of the OPTN\/UNOS database","volume":"106","author":"Bekki","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.hpb.2025.12.027_bib25","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American society of transplantation consensus conference on the use of hepatitis C viremic donors in solid organ transplantation","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/TP.0000000000003014","article-title":"Liver and kidney recipient selection of hepatitis C virus viremic donors: meeting consensus report from the 2019 controversies in transplantation","volume":"104","author":"Burton","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.hpb.2025.12.027_bib27","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/ajt.14447","article-title":"HCV viremic donors with hepatic bridging fibrosis: are we ready to use their livers in the era of direct-acting antivirals?","volume":"17","author":"Martini","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib28","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.29557","article-title":"Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C","volume":"67","author":"Mauro","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2025.12.027_bib31","article-title":"Trends in candidate hepatitis C virus nucleic acid amplification test (NAT)+ listing and associated impacts on liver transplantation waitlist outcomes","author":"Salinas","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib32","article-title":"Hepatitis C-positive grafts for hepatitis C-negative recipients in liver transplantation: buried treasure or depleting resource?","author":"Nakayama","year":"2024","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/SLA.0000000000005071","article-title":"Expanding the donor pool: first use of hepatitis B virus nat positive solid organ allografts into seronegative recipients","volume":"274","author":"Delman","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.12.027_bib34","article-title":"Safety and use of late-turndown liver allografts to increase rate of transplantation","volume":"0","author":"Whitrock","year":"2024","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2025.12.027_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/transplantology5010005","article-title":"Novel study of SARS-CoV-2 RNA in post-reperfusion liver biopsies after transplantation using COVID-19-Positive donor allografts","volume":"5","author":"Whitrock","year":"2024","journal-title":"Transplantology"},{"key":"10.1016\/j.hpb.2025.12.027_bib36","doi-asserted-by":"crossref","first-page":"e13047","DOI":"10.1111\/tid.13047","article-title":"Direct-acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: systematic review and meta-analysis","volume":"21","author":"Liu","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.hpb.2025.12.027_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijsu.2020.01.145","article-title":"Liver transplantation for hepatitis C patients in the era of direct-acting antiviral treatment: a retrospective cohort study","volume":"75","author":"Khan","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.hpb.2025.12.027_bib38","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/TP.0000000000003382","article-title":"Liver transplantation of HCV-viremic donors into HCV-negative recipients in the USA: increasing frequency with profound geographic variation","volume":"105","author":"Cotter","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.hpb.2025.12.027_bib39","article-title":"Viral hepatitis national progress report overview","year":"2024","journal-title":"Viral Hepat"},{"key":"10.1016\/j.hpb.2025.12.027_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15050","article-title":"Progression of fibrosis in liver transplant recipients with hepatitis C before and after sustained virologic response","volume":"37","author":"Liu","year":"2023","journal-title":"Clin Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/HEP.0000000000000873","article-title":"The future of liver transplantation","volume":"80","author":"Feng","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2025.12.027_bib42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/TP.0000000000005174","article-title":"Outcomes of liver transplantation from hepatitis C virus\u2013positive DCD donors and its utilization among centers in the United States","volume":"109","author":"Punjala","year":"2025","journal-title":"Transplantation"},{"key":"10.1016\/j.hpb.2025.12.027_bib43","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/jcm9041046","article-title":"Normothermic machine perfusion (NMP) of the liver as a platform for therapeutic interventions during Ex-Vivo liver preservation: a review","volume":"9","author":"Dengu","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.hpb.2025.12.027_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5500\/wjt.v10.i1.1","article-title":"Therapeutics administered during ex vivo liver machine perfusion: an overview","volume":"10","author":"Buchwald","year":"2020","journal-title":"World J Transplant"},{"key":"10.1016\/j.hpb.2025.12.027_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70148","article-title":"Utilizing machine learning to predict liver allograft fibrosis by leveraging clinical and imaging data","volume":"39","author":"Rabindranath","year":"2025","journal-title":"Clin Transplant"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25017599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25017599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:24:03Z","timestamp":1775121843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X25017599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1365182X25017599"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2025.12.027","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follow up and safety of use of hepatitis C virus discordant liver transplants","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2025.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}